A detailed history of Stiles Financial Services Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Stiles Financial Services Inc holds 44,962 shares of NVO stock, worth $3.93 Million. This represents 1.9% of its overall portfolio holdings.

Number of Shares
44,962
Previous 44,526 0.98%
Holding current value
$3.93 Million
Previous $6.36 Million 15.77%
% of portfolio
1.9%
Previous 2.46%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$119.07 - $145.42 $51,914 - $63,403
436 Added 0.98%
44,962 $5.35 Million
Q2 2024

Aug 01, 2024

BUY
$122.71 - $146.91 $63,563 - $76,099
518 Added 1.18%
44,526 $6.36 Million
Q1 2024

Apr 30, 2024

BUY
$102.11 - $135.92 $139,584 - $185,802
1,367 Added 3.21%
44,008 $5.65 Million
Q4 2023

Jan 26, 2024

BUY
$87.78 - $105.45 $271,327 - $325,945
3,091 Added 7.82%
42,641 $4.41 Million
Q3 2023

Nov 08, 2023

BUY
$90.94 - $199.54 $1.85 Million - $4.07 Million
20,392 Added 106.44%
39,550 $3.6 Million
Q2 2023

Jul 21, 2023

BUY
$155.98 - $172.65 $6,863 - $7,596
44 Added 0.23%
19,158 $3.1 Million
Q1 2023

May 11, 2023

SELL
$132.34 - $159.14 $88,270 - $106,146
-667 Reduced 3.37%
19,114 $3.04 Million
Q4 2022

Jan 27, 2023

SELL
$102.55 - $135.33 $66,965 - $88,370
-653 Reduced 3.2%
19,781 $0
Q3 2022

Nov 02, 2022

BUY
$95.28 - $116.93 $63,075 - $77,407
662 Added 3.35%
20,434 $2.04 Million
Q2 2022

Jul 26, 2022

SELL
$103.24 - $121.81 $1,342 - $1,583
-13 Reduced 0.07%
19,772 $2.2 Million
Q1 2022

May 06, 2022

SELL
$93.1 - $112.54 $44,967 - $54,356
-483 Reduced 2.38%
19,785 $2.2 Million
Q4 2021

Feb 09, 2022

BUY
$95.88 - $117.08 $1.94 Million - $2.37 Million
20,268 New
20,268 $2.25 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Stiles Financial Services Inc Portfolio

Follow Stiles Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stiles Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Stiles Financial Services Inc with notifications on news.